Bacterial News and Research

RSS

Alliqua acquires global license for wound care dressings from Noble Biomaterials

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies today announced that it has acquired from Noble Biomaterials, Inc. a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option.

21 Jul 2011

New rapid test accurately distinguishes bacterial and viral infections

Researchers at Ben-Gurion University of the Negev (BGU) have developed a new test that quickly and accurately distinguishes between bacterial and viral infections in as little as five hours.

21 Jul 2011

Maltodextrin-based imaging probes could improve diagnosis and treatment of bacterial infections

A new family of contrast agents that sneak into bacteria disguised as glucose food can detect bacterial infections in animals with high sensitivity and specificity. These agents -- called maltodextrin-based imaging probes -- can also distinguish a bacterial infection from other inflammatory conditions.

21 Jul 2011

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Johnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010.

19 Jul 2011

EPA to expand Cooperative Research And Development Agreement with NanoLogix

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.

19 Jul 2011

Partners of Bacterial Vaginosis sufferers at increased risk of HIV

Starpharma Holdings Limited today commented on results of a study which showed that men were three times more likely to contract HIV from their female partners if the women also had bacterial vaginosis (BV) in the three months before the men became infected.

18 Jul 2011

Scientists identify key immune system regulator in white blood cells

St. Jude Children's Research Hospital scientists provide insight into immune system biology and identify the mechanism that keeps white blood cell activity at a minimum until the specific immune response is needed.

18 Jul 2011

Researchers closer to developing meningitis B vaccine

"New research may bring scientists one step closer to developing a vaccine that protects against hundreds of strains of meningococcus B, the most common cause of bacterial meningitis," according to research published last week in Science Translational Medicine, HealthDay News reports.

18 Jul 2011

Sodexo selects Xenex as preferred partner for disinfection of client facilities

Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.

18 Jul 2011

Two promising projects focus on new treatments for cystic fibrosis

Two promising projects have been selected to undergo preclinical testing as part of the Cystic Fibrosis Technology Initiative.

14 Jul 2011

UW scientists determine atomic architecture of sodium channel

Scientists at the University of Washington (UW) in Seattle have determined the atomic architecture of a sodium channel. The achievement opens new possibilities for molecular medicine researchers around the world in designing better drugs for pain, epilepsy, and heart rhythm disturbances.

14 Jul 2011

Adamis receives European patent for novel cell-based cancer vaccine technology

Adamis Pharmaceuticals Corporation, today announced the technology which constitutes the basis of a novel cell-based cancer vaccine, TeloB-VAX, was recently granted a patent in Europe.

14 Jul 2011

Biologists discover new way in which bacteria hijack healthy cells during infection

Purdue University biologists identified a new way in which bacteria hijack healthy cells during infection, which could provide a target for new antibiotics.

13 Jul 2011

USPTO issues notice of allowance to MDI's PCR-based technology platform

Molecular Detection Inc. (MDI), a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has received a notice of allowance from the US Patent and Trademark Office (USPTO) for a patent application titled "Methods, Compositions and Kits for Detection and Analysis of Antibiotic Resistant Bacteria."

12 Jul 2011

GlaxoSmithKline's Boostrix receives FDA approval to prevent tetanus, diphtheria, and pertussis

The U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older.

11 Jul 2011

Tips for preventing foodborne illness at home or while eating out

Dr. Melvin Pascall, an associate professor in the Department of Food Science and Technology at The Ohio State University, has spent the past 15 years working to improve food safety in areas ranging from packaging to food service cleaning practices.

11 Jul 2011

Top-line results from HyQ subcutaneous IG phase III study in patients with primary immunodeficiency

Baxter International Inc. and Halozyme Therapeutics, Inc. today announced top-line results of a phase III study of HyQ, an investigational facilitated subcutaneous immune globulin (IG) product for use in patients with primary immunodeficiency (PI).

From Baxter International Inc. 8 Jul 2011

Cloud computing technology shortens development time for new antibiotics

IBM today announced researchers from science and technology university ETH Zurich and CloudBroker, a high-performance cloud computing company, have partnered with IBM to use cloud computing technology to conduct cutting-edge research focused on developing new antibiotics to fight disease.

8 Jul 2011

Infectious adenoviruses and noroviruses in bathing water could pose a risk to health

European researchers have found viruses in nearly 40% of more than 1,400 bathing water samples gathered from coastal and inland areas in nine countries, including Spain. The concentrations found are low, but the scientists are calling for these microorganisms to be monitored in recreational waters, above all at times when their populations skyrocket, as is the case after heavy rains.

8 Jul 2011

New technique shields patients from toxic parts of antibiotic drug

A new technique which targets antibiotic-resistant bacteria and shields patients from the toxic parts of an antibiotic drug has been developed by Cardiff University scientists.

8 Jul 2011